237 related articles for article (PubMed ID: 21294640)
21. [The NAD(P)H: quinone oxidoreductase 1 C609T polymorphism and susceptibility to esophageal cancer].
Zhang JH; Li Y; Wang R; Sarbia M; Guo W; Wen DG; Wei LZ; Chen ZF; Kuang G; Zhang LW; He M; Wu ML; Wang SJ
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2003 Dec; 20(6):544-6. PubMed ID: 14669229
[TBL] [Abstract][Full Text] [Related]
22. Two minor NQO1 and NQO2 alleles predict poor response of breast cancer patients to adjuvant doxorubicin and cyclophosphamide therapy.
Jamieson D; Cresti N; Bray J; Sludden J; Griffin MJ; Hawsawi NM; Famie E; Mould EV; Verrill MW; May FE; Boddy AV
Pharmacogenet Genomics; 2011 Dec; 21(12):808-19. PubMed ID: 21946896
[TBL] [Abstract][Full Text] [Related]
23. The NAD(P)H:quinone oxidoreductase 1 gene polymorphism and lung cancer: differential susceptibility based on smoking behavior.
Xu LL; Wain JC; Miller DP; Thurston SW; Su L; Lynch TJ; Christiani DC
Cancer Epidemiol Biomarkers Prev; 2001 Apr; 10(4):303-9. PubMed ID: 11319169
[TBL] [Abstract][Full Text] [Related]
24. Superoxide dismutase and nicotinamide adenine dinucleotide phosphate: quinone oxidoreductase polymorphisms and pancreatic cancer risk.
Mohelnikova-Duchonova B; Marsakova L; Vrana D; Holcatova I; Ryska M; Smerhovsky Z; Slamova A; Schejbalova M; Soucek P
Pancreas; 2011 Jan; 40(1):72-8. PubMed ID: 20966810
[TBL] [Abstract][Full Text] [Related]
25. No association of NAD(P)H: quinone oxidoreductase 1 (NQO1) C609T polymorphism and risk of hepatocellular carcinoma development in Turkish subjects.
Akkiz H; Bayram S; Bekar A; Akgöllü E; Ülger Y; Kaya BY; Sandikçi M; Özdil B
Asian Pac J Cancer Prev; 2010; 11(4):1051-8. PubMed ID: 21133623
[TBL] [Abstract][Full Text] [Related]
26. [Interaction between polymorphisms in NQO1(C609T) and XRCC1(G28152A) and their correlation with smoking on gastric cancer].
Chen DJ; Ding R; Cao W; Ye DQ
Zhonghua Liu Xing Bing Xue Za Zhi; 2011 Jan; 32(1):5-8. PubMed ID: 21518531
[TBL] [Abstract][Full Text] [Related]
27. Phospholipase C epsilon 1 (PLCE1) haplotypes are associated with increased risk of gastric cancer in Kashmir Valley.
Malik MA; Srivastava P; Zargar SA; Mittal B
Saudi J Gastroenterol; 2014; 20(6):371-7. PubMed ID: 25434319
[TBL] [Abstract][Full Text] [Related]
28. Role of xenobiotic-metabolizing enzyme gene polymorphisms and interactions with environmental factors in susceptibility to gastric cancer in Kashmir Valley.
Malik MA; Upadhyay R; Mittal RD; Zargar SA; Modi DR; Mittal B
J Gastrointest Cancer; 2009; 40(1-2):26-32. PubMed ID: 19521675
[TBL] [Abstract][Full Text] [Related]
29. Clinical significance of a NAD(P)H: quinone oxidoreductase 1 polymorphism in patients with disseminated peritoneal cancer receiving intraperitoneal hyperthermic chemotherapy with mitomycin C.
Fleming RA; Drees J; Loggie BW; Russell GB; Geisinger KR; Morris RT; Sachs D; McQuellon RP
Pharmacogenetics; 2002 Jan; 12(1):31-7. PubMed ID: 11773862
[TBL] [Abstract][Full Text] [Related]
30. Differential gene expression of NAD(P)H:quinone oxidoreductase and NRH:quinone oxidoreductase in human hepatocellular and biliary tissue.
Strassburg A; Strassburg CP; Manns MP; Tukey RH
Mol Pharmacol; 2002 Feb; 61(2):320-5. PubMed ID: 11809856
[TBL] [Abstract][Full Text] [Related]
31. Role of epoxide hydrolase, NAD(P)H:quinone oxidoreductase, cytochrome P450 2E1 or alcohol dehydrogenase genotypes in susceptibility to colorectal cancer.
van der Logt EM; Bergevoet SM; Roelofs HM; Te Morsche RH; Dijk Yv; Wobbes T; Nagengast FM; Peters WH
Mutat Res; 2006 Jan; 593(1-2):39-49. PubMed ID: 16039674
[TBL] [Abstract][Full Text] [Related]
32. Association of the GSTP1 and NQO1 polymorphisms and head and neck squamous cell carcinoma risk.
Cho CG; Lee SK; Nam SY; Lee MS; Lee SW; Choi EK; Park HJ; Kim SY
J Korean Med Sci; 2006 Dec; 21(6):1075-9. PubMed ID: 17179690
[TBL] [Abstract][Full Text] [Related]
33. [Quinone oxidoreductase gene polymorphism and genetic susceptibility to nasopharyngeal carcinoma].
Wu DH
Di Yi Jun Yi Da Xue Xue Bao; 2002 Dec; 22(12):1126-7. PubMed ID: 12480594
[TBL] [Abstract][Full Text] [Related]
34. NAD(P)H: quinone oxidoreductase 1 and NRH:quinone oxidoreductase 2 polymorphisms in papillary thyroid microcarcinoma: correlation with phenotype.
Lee J; Kim KS; Lee MH; Kim YS; Lee MH; Lee SE; Kim YK; Ryu MJ; Kim SJ; Choi MJ; Jo YS
Yonsei Med J; 2013 Sep; 54(5):1158-67. PubMed ID: 23918565
[TBL] [Abstract][Full Text] [Related]
35. Quinone oxidoreductase (NQO1) gene polymorphism (609C/T) may be associated with tardive dyskinesia, but not with the development of schizophrenia.
Pae CU; Yu HS; Kim JJ; Lee CU; Lee SJ; Jun TY; Lee C; Paik IH
Int J Neuropsychopharmacol; 2004 Dec; 7(4):495-500. PubMed ID: 15151706
[TBL] [Abstract][Full Text] [Related]
36. Clinical Significance of the NQO1 C609T Polymorphism in Non Small Cell Lung Adenocarcinoma Patients.
Masroor M; Jain A; Javid J; Mir R; Prashant Y; Imtiyaz A; Mariyam Z; Mohan A; Ray PC; Saxena A
Asian Pac J Cancer Prev; 2015; 16(17):7653-8. PubMed ID: 26625776
[TBL] [Abstract][Full Text] [Related]
37. Association of bladder cancer risk with an NAD(P)H:quinone oxidoreductase polymorphism in an ethnic Kashmiri population.
Pandith AA; Khan NP; Shah ZA; Shah AM; Wani SM; Siddiqi MA
Biochem Genet; 2011 Aug; 49(7-8):417-26. PubMed ID: 21253823
[TBL] [Abstract][Full Text] [Related]
38. NQO1 rs1800566 C>T polymorphism was associated with a decreased risk of esophageal cancer in a Chinese population.
Yin J; Wang L; Wang X; Zheng L; Shi Y; Shao A; Tang W; Ding G; Liu C; Liu R; Chen S; Gu H
Scand J Gastroenterol; 2014 Mar; 49(3):317-22. PubMed ID: 24354914
[TBL] [Abstract][Full Text] [Related]
39. Human NAD(P)H:quinone oxidoreductase 1 (NQO1) and sulfotransferase 1A1 (SULT1A1) polymorphisms and urothelial cancer risk in Taiwan.
Wang YH; Lee YH; Tseng PT; Shen CH; Chiou HY
J Cancer Res Clin Oncol; 2008 Feb; 134(2):203-9. PubMed ID: 17619904
[TBL] [Abstract][Full Text] [Related]
40. The influence of fruit and vegetable consumption and genetic variation on NAD(P)H:quinone oxidoreductase (NQO1) phenotype in an endoscopy-based population.
Tijhuis MJ; Boerboom AM; Visker MH; Op den Camp L; Nagengast FM; Tan AC; Rietjens IM; Kok FJ; Aarts JM; Kampman E
Nutr Cancer; 2008; 60(2):204-15. PubMed ID: 18444152
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
